Samuel LaBarge joined the Genea Biocells team on August 15, 2017 as a Senior Scientist. Dr. LaBarge earned a bachelor of science in Chemical Engineering from Rensselaer Polytechnic Institute in Troy, NY. He then pursued a Ph.D. in Biological Sciences at the Irell and Manella Graduate School of Biological Sciences at City of Hope in Duarte, CA. Upon graduating in 2014, Dr. LaBarge moved to UC San Diego to begin a postdoctoral position in the laboratory of Dr. Simon Schenk. Dr. LaBarge’s training and experience has spanned several fields, from chemical engineering, and molecular biology, to integrative physiology. His recent work has focused on transcriptional regulation of metabolism, skeletal muscle adaptation to exercise and calorie restriction, as well as non-canonical mechanisms that regulate insulin stimulated glucose uptake. Dr. LaBarge has an underlying interest in aging biology and therapeutics to treat unmet orphan diseases. At Genea Biocells, Dr. LaBarge is focused on therapeutic drug discovery for orphan neuromuscular diseases by utilizing muscle cells differentiated from ethically derived human pluripotent stem cells. For more information, please visit our website: Genea Biocells.
Please follow and like us: